Enfusion, Inc. (ENFN)
Apr 21, 2025 - ENFN was delisted (reason: acquired by CWAN)
10.76
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2025
Enfusion Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 54.48 | 35.6 | 62.55 | 64.37 | 13.94 |
Cash & Short-Term Investments | 54.48 | 35.6 | 62.55 | 64.37 | 13.94 |
Cash Growth | 53.02% | -43.08% | -2.83% | 361.80% | 136.32% |
Receivables | 31.99 | 28.07 | 25.86 | 18.22 | 12.18 |
Prepaid Expenses | 5.34 | 5.01 | 6.11 | 6.03 | 2.79 |
Other Current Assets | 1.71 | 1.17 | 2.3 | 1.06 | - |
Total Current Assets | 93.52 | 69.85 | 96.81 | 89.68 | 28.91 |
Property, Plant & Equipment | 39.03 | 32.62 | 22.49 | 13.05 | 8.78 |
Long-Term Deferred Charges | 4.6 | 3.5 | 2.8 | - | - |
Other Long-Term Assets | 3.12 | 3 | 1.68 | 3.36 | 1.4 |
Total Assets | 143.26 | 108.97 | 123.78 | 106.09 | 39.1 |
Liabilities
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.87 | 2.21 | 1.69 | 2.53 | 0.48 |
Accrued Expenses | 19 | 11.44 | 11.38 | 4.36 | 6.96 |
Current Portion of Long-Term Debt | - | - | - | - | 2.5 |
Current Portion of Leases | 6.08 | 4.26 | 4.03 | - | - |
Current Income Taxes Payable | 1.4 | 2.4 | 0.29 | 1.22 | 0.41 |
Other Current Liabilities | - | - | - | - | 0.3 |
Total Current Liabilities | 27.34 | 20.31 | 17.38 | 8.11 | 10.65 |
Long-Term Debt | - | - | - | - | 96.06 |
Long-Term Leases | 14.24 | 11.18 | 2.96 | - | - |
Other Long-Term Liabilities | 2.15 | - | - | 0.54 | 0.43 |
Total Liabilities | 43.72 | 31.49 | 20.34 | 8.64 | 107.14 |
Shareholders' Equity
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0.13 | 0.13 | 0.11 | 0.11 | -233.35 |
Additional Paid-In Capital | 243.94 | 226.88 | 244.26 | 226.72 | - |
Retained Earnings | -170.11 | -172.93 | -178.86 | -171.21 | - |
Comprehensive Income & Other | -0.73 | -0.41 | -0.5 | -0.33 | -0.21 |
Total Common Equity | 73.22 | 53.67 | 65.01 | 55.3 | -233.56 |
Minority Interest | 26.32 | 23.82 | 38.44 | 42.15 | - |
Shareholders' Equity | 99.54 | 77.48 | 103.44 | 97.44 | -68.04 |
Total Liabilities & Equity | 143.26 | 108.97 | 123.78 | 106.09 | 39.1 |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 20.31 | 15.44 | 6.99 | - | 98.56 |
Net Cash (Debt) | 34.17 | 20.17 | 55.56 | 64.37 | -84.63 |
Net Cash Growth | 69.42% | -63.70% | -13.69% | - | - |
Net Cash Per Share | 0.26 | 0.16 | 0.65 | 0.78 | -1764.20 |
Filing Date Shares Outstanding | 94.8 | 89.87 | 73.07 | 65.58 | 0.05 |
Total Common Shares Outstanding | 94.66 | 88.33 | 70.86 | 65.58 | 0.05 |
Working Capital | 66.19 | 49.54 | 79.43 | 81.57 | 18.26 |
Book Value Per Share | 0.77 | 0.61 | 0.92 | 0.84 | -4869.06 |
Tangible Book Value | 73.22 | 53.67 | 65.01 | 55.3 | -233.56 |
Tangible Book Value Per Share | 0.77 | 0.61 | 0.92 | 0.84 | -4869.06 |
Machinery | 20.2 | 17.52 | 17.93 | 14.7 | 9.2 |
Leasehold Improvements | 2.03 | 1.67 | 1.83 | 1.95 | 1.41 |